ArriVent Announces Pricing of $75 Million Public Offering - GlobeNewswire

Retrieved on: 2025-07-02 15:16:56

Tags for this article:

Financial markets

Initial public offering

Stock market

U.S. Securities and Exchange Commission

Corporate finance

Prospectus

Forward-looking statement

Shelf registration

Registration statement

Goldman Sachs

Security

Public offering

ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

ArriVent Announces Pricing of $75 Million Public Offering - GlobeNewswire. View article details on hiswai:

Excerpt

... BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical ...

Article found on: www.globenewswire.com

View Original Article